Guest Speaker Robert Holley, Pharmaceutical/Vaccine Industry Expert

| April 11, 2011

article image
At the Gateway Analytical grand opening event guest speaker Robert Holley, who is a pharmaceutical/vaccine industry expert talked about why utilizing contract laboratories that specialize in pharmaceutical forensics for issues such as determining a particle contaminate in the manufacturing process can be very cost effective and time saving.

Spotlight

Pharma Right Group

Pharma Right Group is a cluster of 3 leading pharmaceutical companies (Pharma Right, RAI Pharmaceuticals, and Empire Pharma), with a diversified & integrated portfolio in pharmaceutical business Pharma Right Group has a believe& primary focus to be a healthcare provider in Egypt ,North Africa and Middle East region with innovative, high quality, and affordable healthcare products in different therapeutic areas like G.I.T, Anti-Infectives ,Cosmoceuticals and Neuroscience. We have the passion to think differently to do right things & drive up community health.

OTHER ARTICLES

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | February 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | March 11, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | March 2, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

Spotlight

Pharma Right Group

Pharma Right Group is a cluster of 3 leading pharmaceutical companies (Pharma Right, RAI Pharmaceuticals, and Empire Pharma), with a diversified & integrated portfolio in pharmaceutical business Pharma Right Group has a believe& primary focus to be a healthcare provider in Egypt ,North Africa and Middle East region with innovative, high quality, and affordable healthcare products in different therapeutic areas like G.I.T, Anti-Infectives ,Cosmoceuticals and Neuroscience. We have the passion to think differently to do right things & drive up community health.

Events